| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 14 | +57.14% | +11.12% | +0.85% | +10.27% | +4.22% | — |
| 14d | 14 | +41.67% | +7.12% | +1.40% | +6.62% | -0.33% | — |
| 30d | 14 | +70.00% | +16.34% | +2.19% | +13.43% | +4.76% | — |
| 60d | 14(4 pending) | +90.00% | +15.48% | +3.40% | +12.09% | +14.23% | — |
| 90d | 14(4 pending) | +90.00% | +13.70% | +4.60% | +9.11% | +5.50% | — |
| 180d | 14(4 pending) | +30.00% | -2.33% | +10.09% | -12.42% | -26.51% | — |
| 1y | 14(4 pending) | +80.00% | +2.72% | +20.99% | -18.27% | -18.42% | — |
| 2y | 14(4 pending) | +60.00% | -7.80% | +30.46% | -38.26% | -78.86% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| PTGX PROTAGONIST THERAPEUTICS, INC | SALE | 5,130 | $100.00 | $513.0K | 12,695 | May 8, 2026 | May 11, 2026 ↗ | View → |
| PTGX PROTAGONIST THERAPEUTICS, INC | SALE | 6,000 | $100.00 | $600.0K | 0 | May 8, 2026 | May 11, 2026 ↗ | View → |
| PTGX PROTAGONIST THERAPEUTICS, INC | SALE | 12,000 | — | — | 0 | May 7, 2026 | May 11, 2026 ↗ | View → |
| PTGX PROTAGONIST THERAPEUTICS, INC | SALE | 24,000 | — | — | 0 | May 7, 2026 | May 11, 2026 ↗ | View → |
| PTGX PROTAGONIST THERAPEUTICS, INC | SALE | 36,000 | $100.14 | $3.61M | 27,825 | May 7, 2026 | May 11, 2026 ↗ | View → |
| PTGX PROTAGONIST THERAPEUTICS, INC | SALE | 12,000 | $100.07 | $1.20M | 6,000 | May 7, 2026 | May 11, 2026 ↗ | View → |
| PTGX PROTAGONIST THERAPEUTICS, INC | PURCHASE | 12,000 | $6.98 | $83.8K | 43,825 | May 7, 2026 | May 11, 2026 ↗ | View → |
| PTGX PROTAGONIST THERAPEUTICS, INC | PURCHASE | 24,000 | $6.45 | $154.8K | 31,825 | May 7, 2026 | May 11, 2026 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | SALE COO/CFO | 543,750 | — | — | 0 | Mar 19, 2026 | Mar 20, 2026 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 100,000 | — | — | 100,000 | Mar 19, 2026 | Mar 20, 2026 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 181,250 | — | — | 181,250 | Mar 19, 2026 | Mar 20, 2026 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | SALE COO/CFO | 693,750 | — | — | 0 | Mar 19, 2026 | Mar 20, 2026 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | SALE COO/CFO | 176,667 | — | — | 0 | Mar 19, 2026 | Mar 20, 2026 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | SALE COO/CFO | 181,250 | — | — | 0 | Mar 19, 2026 | Mar 20, 2026 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | SALE COO/CFO | 211,500 | — | — | 0 | Mar 19, 2026 | Mar 20, 2026 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 176,667 | — | — | 176,667 | Mar 19, 2026 | Mar 20, 2026 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 543,750 | — | — | 543,750 | Mar 19, 2026 | Mar 20, 2026 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 211,500 | — | — | 211,500 | Mar 19, 2026 | Mar 20, 2026 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | SALE COO/CFO | 100,000 | — | — | 0 | Mar 19, 2026 | Mar 20, 2026 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 638,000 | — | — | 638,000 | Mar 19, 2026 | Mar 20, 2026 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 96,667 | — | — | 96,667 | Mar 19, 2026 | Mar 20, 2026 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 693,750 | — | — | 693,750 | Mar 19, 2026 | Mar 20, 2026 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | SALE COO/CFO | 638,000 | — | — | 0 | Mar 19, 2026 | Mar 20, 2026 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | SALE COO/CFO | 96,667 | — | — | 0 | Mar 19, 2026 | Mar 20, 2026 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | SALE COO/CFO | 60,000 | — | — | 0 | Mar 19, 2026 | Mar 20, 2026 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 60,000 | — | — | 60,000 | Mar 19, 2026 | Mar 20, 2026 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | SALE COO/CFO | 47,667 | — | — | 0 | Mar 19, 2026 | Mar 20, 2026 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 47,667 | — | — | 47,667 | Mar 19, 2026 | Mar 20, 2026 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 115,750 | — | — | 389,737 | Jan 2, 2026 | Jan 5, 2026 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 693,750 | — | — | 693,750 | Jan 2, 2026 | Jan 5, 2026 ↗ | View → |
| PTGX PROTAGONIST THERAPEUTICS, INC | PURCHASEGRANT Stock grant | 3,762 | — | — | 3,762 | Jan 2, 2026 | Jan 6, 2026 ↗ | View → |
| PTGX PROTAGONIST THERAPEUTICS, INC | PURCHASEGRANT Stock grant | 2,695 | — | — | 17,825 | Jan 2, 2026 | Jan 6, 2026 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 181,250 | — | — | 273,987 | Oct 1, 2025 | Oct 2, 2025 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 638,000 | — | — | 638,000 | Mar 4, 2025 | Mar 6, 2025 ↗ | View → |
| PTGX PROTAGONIST THERAPEUTICS, INC | PURCHASEGRANT Stock grant | 6,584 | — | — | 6,584 | Jan 2, 2025 | Jan 6, 2025 ↗ | View → |
| PTGX PROTAGONIST THERAPEUTICS, INC | PURCHASEGRANT Stock grant | 5,130 | — | — | 15,130 | Jan 2, 2025 | Jan 6, 2025 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASE COO/CFO | 100,000 | $0.59 | $59.1K | 480,010 | Jun 18, 2024 | Jun 20, 2024 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | SALE COO/CFO | 6,430 | $1.16 | $7.4K | 92,737 | Mar 27, 2024 | Mar 28, 2024 ↗ | View → |
| PTGX PROTAGONIST THERAPEUTICS, INC | PURCHASEGRANT Stock grant | 25,700 | — | — | 25,700 | Jan 2, 2024 | Jan 4, 2024 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 543,750 | — | — | 543,750 | Jan 2, 2024 | Jan 4, 2024 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 181,250 | — | — | 181,250 | Nov 20, 2023 | Nov 22, 2023 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASE COO/CFO | 200,000 | $0.56 | $112.9K | 380,010 | Nov 13, 2023 | Nov 14, 2023 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 54,020 | $1.82 | $98.3K | 180,010 | Jul 24, 2023 | Jul 26, 2023 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 13,505 | $0.13 | $1.7K | 13,505 | Jul 24, 2023 | Jul 26, 2023 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 60,000 | — | — | 60,000 | May 5, 2023 | May 9, 2023 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 100,000 | — | — | 100,000 | May 5, 2023 | May 9, 2023 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | SALE COO/CFO | 150,000 | — | — | 0 | May 5, 2023 | May 9, 2023 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 96,667 | — | — | 96,667 | May 5, 2023 | May 9, 2023 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 47,667 | — | — | 47,667 | May 5, 2023 | May 9, 2023 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | SALE COO/CFO | 71,500 | — | — | 0 | May 5, 2023 | May 9, 2023 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | SALE COO/CFO | 265,000 | — | — | 0 | May 5, 2023 | May 9, 2023 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 176,667 | — | — | 176,667 | May 5, 2023 | May 9, 2023 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | SALE COO/CFO | 90,000 | — | — | 0 | May 5, 2023 | May 9, 2023 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | SALE COO/CFO | 145,000 | — | — | 0 | May 5, 2023 | May 9, 2023 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASE COO/CFO | 55,000 | $1.02 | $56.1K | 125,990 | Apr 4, 2023 | Apr 5, 2023 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASE COO/CFO | 50,000 | $0.97 | $48.4K | 70,990 | Mar 20, 2023 | Mar 22, 2023 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 211,500 | — | — | 211,500 | Mar 20, 2023 | Mar 22, 2023 ↗ | View → |
| PTGX PROTAGONIST THERAPEUTICS, INC | PURCHASEGRANT Stock grant | 30,000 | — | — | 30,000 | Jan 16, 2023 | Jan 18, 2023 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 211,500 | — | — | 211,500 | Dec 7, 2022 | Dec 9, 2022 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASE COO/CFO | 13,869 | $7.21 | $100.0K | 20,990 | Jul 15, 2022 | Jul 15, 2022 ↗ | View → |
| PTGX PROTAGONIST THERAPEUTICS, INC | PURCHASEGRANT Stock grant | 20,000 | — | — | 20,000 | May 26, 2022 | May 27, 2022 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | SALE COO/CFO | 10,722 | $8.92 | $95.6K | 99,167 | Mar 23, 2022 | Mar 24, 2022 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 265,000 | — | — | 265,000 | Jan 6, 2022 | Jan 10, 2022 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 150,000 | — | — | 150,000 | Sep 16, 2021 | Sep 20, 2021 ↗ | View → |
| PTGX PROTAGONIST THERAPEUTICS, INC | PURCHASEGRANT Stock grant | 18,000 | — | — | 18,000 | May 27, 2021 | May 28, 2021 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | SALE Chief Financial Officer | 5,490 | $9.48 | $52.0K | 109,889 | Mar 23, 2021 | Mar 25, 2021 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 45,000 | — | — | 115,379 | Feb 25, 2021 | Mar 1, 2021 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 90,000 | — | — | 90,000 | Feb 25, 2021 | Mar 1, 2021 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASE Chief Financial Officer | 3,000 | $10.01 | $30.0K | 7,121 | Oct 14, 2020 | Oct 14, 2020 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASE Chief Financial Officer | 2,000 | $12.96 | $25.9K | 4,121 | Jun 23, 2020 | Jun 23, 2020 ↗ | View → |
| PTGX PROTAGONIST THERAPEUTICS, INC | PURCHASEGRANT Stock grant | 15,000 | — | — | 15,000 | May 28, 2020 | May 29, 2020 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 46,500 | — | — | 70,379 | Feb 14, 2020 | Feb 19, 2020 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 71,500 | — | — | 71,500 | Feb 14, 2020 | Feb 19, 2020 ↗ | View → |